Day: November 7, 2019

NE PAS DISTRIBUER À DES AGENCES DE PRESSE DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS-UNISTORONTO, 07 nov. 2019 (GLOBE NEWSWIRE) — Amex Exploration inc. (la “Société”) (TSXV: AMX) est heureuse d’annoncer la clôture du placement privé effectué par l’entremise d’un courtier annoncé précédemment pour un produit brut total de 8 000 100 $ (le “Placement”).Dans le cadre du Placement, la Société a émis, conformément à un placement privé par voie de prise ferme, un total de 4 444 500 unités accréditives (chacune une “Unité accréditive”), dont les actions ordinaires sous-jacentes constituent des « actions accréditives » au sens du paragraphe 66(15) de la Loi de l’impôt sur le revenu (Canada) et de l’article 359.1 de la Loi sur les impôts (Québec) au prix de 1,80 $ par Unité accréditive. Chaque Unité accréditive consiste en une action ordinaire...

SAN FRANCISCO, CA, Nov. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — APT Systems, Inc. (OTC Pink: APTY), publicly-traded, fintech company, acknowledged its electronics recycling subsidiary is becoming increasingly important as revenue continues to grow month over month.CEO of APT Systems, Glenda Dowie said, “It is rewarding to see income from the AUREX Trading and Recovery operations. October sales alone exceeded the combined sales of July through September. E-waste mining for precious metal is big business and it’s really good for the planet too.  We continue to see those last-generation iPhones, tablets and obsolete computers as a huge opportunity going forward.”The www.TheRefiningCompany.com website continues to deliver daily inquiries to assist customers with processing and refining precious metal.  November sales looks...

Paris, November 7, 2019, 8.30pmAB Science announces positive top-line Phase 3 results for oral masitinib in severe asthmaMasitinib statistically significantly reduced the rate of severe asthma exacerbations compared to placeboAB Science SA (Euronext – FR0010557264 – AB) today announced that the Phase 3 study (AB07105) evaluating oral masitinib in severe asthma uncontrolled by oral corticosteroids met its primary endpoint (p=0.0103).  The pre-specified primary endpoint of the protocol was the severe asthma exacerbation rate. The results on the primary endpoint remained statistically significant across all pre-specified sensitivity analyses, indicating that the results are consistent and robust.In particular, the treatment effect was significant in two pre-specified populations: 1) with severe asthma that were not well controlled...

Paris, 7 novembre 2019, 20h30AB Science annonce des résultats de phase 3 positifs du masitinibdans l’asthme sévèreLe masitinib a réduit de façon statistiquement significative le taux d’exacerbations sévèresde l’asthme par rapport au placeboAB Science SA (Euronext – FR0010557264 – AB) annonce aujourd’hui que l’étude de phase 3 (AB07015) évaluant le masitinib administré par voie orale dans le traitement de l’asthme sévère non contrôlé par les corticoïdes oraux a atteint son objectif principal (p=0.0103). Le critère d’évaluation principal prédéfini dans le protocole de l’étude était le taux d’exacerbation de l’asthme sévère. Les résultats sur le critère d’évaluation principal sont confirmés par toutes les analyses de sensibilité prédéfinies, ce qui indique que ces résultats sont cohérents et robustes.En...

DALLAS, Nov. 07, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE – Puration, Inc. (USOTC: PURA) today confirmed the company is actively developing additional acquisition opportunities similar to the recently announced acquisition developing in Germany.  Earlier this week, PURA announced executing a letter of intent to acquire a company headquartered in Germany as part of a strategy to bottle PURA’s CBD infused beverages locally.  The German LOI follows PURA recently signing a distribution agreement in Europe for its EVERx CBD Sports Water with other CBD infused beverages to follow.  The initial European distribution agreement is estimated to add $4 million in sales next year.  Management indicates that the potential of European distribution beyond the initial $4 million projection warrants the establishment of a local bottling capacity. ...

AUSTIN, Texas , Nov. 07, 2019 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN), will release third-quarter 2019 results after the stock market closes on Thursday, November 14, 2019. The company will provide a pre-recorded transcript that will be available on the Phunware’s Investor Relations website at investors.phunware.com/.Disclosure InformationPhunware uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the company’s Investor Relations website, in addition to following the company’s press releases, SEC filings, public conference calls, presentations and webcasts.About Phunware, Inc.Everything You Need to Succeed on Mobile — Transforming Digital Human...

Iceland Seafood International (“Iceland Seafood”) is delighted to announce it has agreed heads of terms with GPG seafood ehf and IceMar ehf, the current owners of Elba S.L. (“Elba”) to acquire the Barcelona based company which will be a great addition to Iceland Seafood’s South European operation.The heads of terms are signed with the intention of both parties to conclude a share purchase agreement as soon as possible. The proposed acquisition will be subject to customary Due Diligence review and board approval. The intention is to have the conditions fulfilled before year end 2019. Elba S.L. is a strong seafood player in Spain, focussing on frozen light salted products.  The company is based in Barcelona and operates a production facility with total sales volume of 2.200MT per year.  Products are sold under the ElBa brand, which has...

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 7 November 2019Final settlement with US Department of JusticeFollowing the press release of 26 June 2019 regarding the settlement in principle, Fagron today announces that it has reached a final settlement with the US Department of Justice regarding the previously announced civil investigation in the context of the sector-wide investigation into the pricing of pharmaceutical products. As previously communicated, and already provided for in the results of the first half of 2019, the final settlement entails a payment by Fagron of US$ 22.3 million.The settlement agreement with the US Department of Justice does not contain an admission of wrongdoing, fault or liability of any kind by Fagron. With this settlement, all ongoing investigations by the US Department of Justice...

Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 7 november 2019Definitieve schikking met Amerikaanse Ministerie van JustitieIn navolging van het persbericht van 26 juni 2019 over de principeschikking maakt Fagron vandaag bekend een definitieve schikking met het Amerikaanse Ministerie van Justitie te hebben getroffen inzake het eerder bekendgemaakte civielrechtelijk onderzoek in het kader van het sectorbrede onderzoek naar de prijsstelling van farmaceutische producten. Zoals eerder bekendgemaakt en in het eerste halfjaar reeds voorzien, betreft de definitieve schikking een betaling door Fagron van US$ 22,3 miljoen.De schikkingsovereenkomst met het Amerikaanse ministerie van Justitie vormt geen erkenning door Fagron van enige misstand, schuld of aansprakelijkheid van welke aard dan ook. Door deze schikking worden alle...

Purchase of own shares by reverse offer in accordance with General Shareholders‘ Meeting resolution of 21 March 2019The Board of Directors of Festi hf. has decided to launch a purchase of own shares amounting to a maximum of 2% of the outstanding shares. The Purchase price shall not exceed the higher of (i) the share price of the latest independent trade and (ii) the highest current independent bid where the shares a registered for trading, which ever is higher.The company has concluded an agreement with the securities dealer Íslenskir fjárfestar hf. to oversee the buyback in the form of a reverse offer. All shareholders of Festi hf. are eligible to submit offers for purchase of their shares to Íslenskir fjárfestar hf.The offers shall be submitted to Íslenskir fjárfestar to the e-mail address markadir@fjarfestar.is or by phone +354 532-8000...